| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84646 |
N3-PEG4-vc-PAB-Doxorubicin 叠氮PEG修饰维生素C-阿霉素的介绍 |
275 |
zyl |
2024-12-19 |
| 84647 |
DOTA-Ahx-(d-Lys6-GnRH1)DOTA偶联的d-Lys6-GnRH肽 |
174 |
h |
2024-12-19 |
| 84648 |
DOTA-porphyrin 双功能螯合剂DOTA偶联5-(对-氨基-丙烯-氧苯基)-10,15,20-三-(对-羧基-甲基-烯-氧苯基)卟啉 |
192 |
h |
2024-12-19 |
| 84649 |
VC-SECO DUBA analogue，ADC定制 |
150 |
wyh |
2024-12-19 |
| 84650 |
DOTA-H-Lys(Boc)-OH-SWCNTs 赖氨酸胺手柄功能化的单壁碳纳米管偶联DOTA螯合剂 |
144 |
h |
2024-12-19 |
| 84651 |
[DOTA-A1]-ZHER2:S1 抗HER2 ZHER2:S1亲和体分子缀合DOTA |
243 |
h |
2024-12-19 |
| 84652 |
Vc-MMAD cas:1401963-17-4的结构式 |
138 |
zyl |
2024-12-19 |
| 84653 |
DOTA-E(c(RGDfK))大环DOTA偶联双环肽E[c(RGDfK)] |
159 |
h |
2024-12-19 |
| 84654 |
CL2A-SN38，cas:1279680-68-0，ADC定制 |
267 |
wyh |
2024-12-19 |
| 84655 |
DOTA-gluBBN DOTA缀合铃蟾肽类似物 |
157 |
h |
2024-12-19 |
| 84656 |
DOTA-GSG-KCCYSL DOTA缀合物ErbB-2靶向肽KCCYSL |
223 |
h |
2024-12-19 |
| 84657 |
MC-MMAF ， cas:863971-19-1，ADC定制 |
170 |
wyh |
2024-12-19 |
| 84658 |
TCO-PEG4-Fmoc-Gly-Gly-Gly-ADC连接子 |
196 |
zyl |
2024-12-19 |
| 84659 |
模拟肽4-[2-(3,4,5,6-四氢嘧啶-2-基氨基)乙氧基]苯甲酰基-2-[N-(3-氨基-新戊-1-氨基甲酰基)]-氨乙基磺酰基-氨基-β-丙氨酸(IAC)缀合DOTA |
165 |
h |
2024-12-19 |
| 84660 |
DOTA-chCE7 DOTA标记的糖基化单克隆抗L1-CAM抗体chCE7 |
167 |
h |
2024-12-19 |
| 84661 |
Vc-MMAE， cas:646502-53-6，ADC定制 |
244 |
wyh |
2024-12-19 |
| 84662 |
Azido-PEG4-MMAE |
173 |
zyl |
2024-12-19 |
| 84663 |
cas:2055024-59-2，Fmoc-PEG2-Val-Cit-PAB-OH |
181 |
zyl |
2024-12-19 |
| 84664 |
Azide-PEG6-Val-Cit-PAB-PEG6- Biotin，ADC定制 |
169 |
wyh |
2024-12-19 |
| 84665 |
Ga-DOTA-(Asp)n 大环DOTA共轭(Asp)n肽 |
136 |
h |
2024-12-19 |
| 84666 |
cas:1807530-16-0，2-hydroxyethyl disulfide mono-Tosylate- ADC linker |
195 |
zyl |
2024-12-19 |
| 84667 |
DOTA偶联受体特异性肽 |
170 |
h |
2024-12-19 |
| 84668 |
聚乙二醇化DOTA-AHA基GdIII螯合物 PEGylated DOTA-based gadolinium(III) |
195 |
h |
2024-12-19 |
| 84669 |
PAMAM树状大分子DOTA缀合物 PAMAM–DOTA |
179 |
h |
2024-12-19 |
| 84670 |
ALD-tetra-EG-Osu的介绍 |
216 |
zyl |
2024-12-19 |
| 84671 |
SSTR2靶向肽Tyr(3)-奥曲肽(tate) |
323 |
h |
2024-12-19 |
| 84672 |
DOTA-D-Phe(1)-Tyr(3)-Octreotide |
172 |
h |
2024-12-19 |
| 84673 |
cas:55750-63-5，Mal-heptanoic NHS ester |
204 |
zyl |
2024-12-19 |
| 84674 |
DOTA-Fab-PEG24-EGF DOTA-PEG修饰曲妥珠单抗Fab片段偶联表皮生长因子 |
176 |
h |
2024-12-19 |
| 84675 |
cas:663599-10-8，DMAC-SPP |
187 |
zyl |
2024-12-19 |
| 84676 |
多甲基化的1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)配体 |
217 |
h |
2024-12-19 |
| 84677 |
PEG-pGlu(DOTA)8-LA4 |
104 |
h |
2024-12-19 |
| 84678 |
cas:937025-17-7，2,5-Dioxopyrrolidin-1-yl 2-oxo-6,9,12,15-tetraoxa-3-thiaoctadecan-18-oate |
190 |
zyl |
2024-12-19 |
| 84679 |
DOTA-Hyd-TRP PET示踪剂 |
170 |
h |
2024-12-19 |
| 84680 |
Ga-DOTATOC Ga-DOTA-D-Phe-Tyr-奥曲肽 |
248 |
h |
2024-12-19 |
| 84681 |
cas:1226371-65-8，N-(2-(2,5-Dimethylphenoxy)ethyl)-4-formylbenzamide |
138 |
zyl |
2024-12-19 |
| 84682 |
DOTA-ALN DOTA-阿仑膦酸盐 |
146 |
h |
2024-12-19 |
| 84683 |
氨氯地平DOTA偶联物 DOTA-Amlodipine |
276 |
h |
2024-12-19 |
| 84684 |
cas:906564-59-8，Propargyl-C2-NHS ester |
158 |
zyl |
2024-12-19 |
| 84685 |
DOTA-Gp2-EGFR DOTA螯合剂标记结合表皮生长因子受体EGFR靶向Gp2 |
145 |
h |
2024-12-19 |
| 84686 |
cas:894095-98-8，β-D-glucuronide-pNP-carbonate |
140 |
zyl |
2024-12-19 |
| 84687 |
DOTA结合肽功能化金纳米粒子 |
165 |
h |
2024-12-19 |
| 84688 |
90Y-DOTA-Bn 钇-90-DOTA-铃蟾肽 |
235 |
h |
2024-12-19 |
| 84689 |
cas:85916-13-8，NH-bis(C1-Boc)，亚氨基二乙酸二异丁酯 |
193 |
zyl |
2024-12-19 |
| 84690 |
Anti-CD19 (clone huB4)-Mc-MMAF-ADC分子 |
111 |
zyl |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询